Emergence of a Novel Dengue Virus 3 (DENV-3) Genotype-I Coincident with Increased DENV-3 Cases in Yangon, Myanmar between 2017 and 2019.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
16 06 2021
Historique:
received: 30 04 2021
revised: 07 06 2021
accepted: 11 06 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 17 8 2021
Statut: epublish

Résumé

Dengue fever, caused by the mosquito-borne dengue virus (DENV), has been endemic in Myanmar since 1970 and it has become a significant public health burden. It is crucial that circulating DENV strains are identified and monitored, and that their transmission efficiency and association with disease severity is understood. In this study, we analyzed DENV-1, DENV-2, DENV-3, and DENV-4 serotypes in 1235 serum samples collected in Myanmar between 2017 and 2019. Whole-genome sequencing of DENV-1-4 demonstrated that most DENV-1-4 strains had been circulating in Myanmar for several years. We also identified the emergence of DENV-3 genotype-I in 2017 samples, which persisted through 2018 and 2019. The emergence of the strain coincided with a period of increased DENV-3 cases and marked changes in the serotype dynamics. Nevertheless, we detected no significant differences between serum viral loads, disease severity, and infection status of individuals infected with different DENV serotypes during the 3-year study. Our results not only identify the spread of a new DENV-3 genotype into Yangon, Myanmar, but also support the importance of DENV evolution in changing the epidemic dynamics in endemic regions.

Identifiants

pubmed: 34208667
pii: v13061152
doi: 10.3390/v13061152
pmc: PMC8235066
pii:
doi:

Types de publication

Historical Article Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Sci Rep. 2017 Feb 24;7:43169
pubmed: 28233799
Trop Med Health. 2015 Mar;43(1):21-7
pubmed: 25859150
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
Virology. 2002 Sep 15;301(1):148-56
pubmed: 12359455
Microorganisms. 2021 Feb 04;9(2):
pubmed: 33557307
Adv Virus Res. 2003;59:315-41
pubmed: 14696333
Infect Genet Evol. 2016 Sep;43:31-7
pubmed: 27154331
J Clin Microbiol. 2004 Dec;42(12):5935-7
pubmed: 15583346
Vector Borne Zoonotic Dis. 2010 Mar;10(2):143-50
pubmed: 19874185
Clin Epidemiol. 2013 Aug 20;5:299-309
pubmed: 23990732
Asian Pac J Cancer Prev. 2020 Sep 01;21(9):2763-2769
pubmed: 32986378
PLoS One. 2019 Aug 15;14(8):e0221179
pubmed: 31415663
Nucleic Acids Res. 2012 Dec;40(22):11189-201
pubmed: 23066108
Genome Res. 2012 Mar;22(3):568-76
pubmed: 22300766
BMC Genomics. 2013 Oct 03;14:674
pubmed: 24088188
Epidemiol Infect. 2017 Jul;145(9):1886-1897
pubmed: 28414004
Cell. 2002 Mar 8;108(5):717-25
pubmed: 11893341
J Clin Microbiol. 1992 Mar;30(3):545-51
pubmed: 1372617
Am J Trop Med Hyg. 2009 Jun;80(6):1039-46
pubmed: 19478273
Emerg Infect Dis. 2014 Aug;20(8):1378-81
pubmed: 25062511
J Clin Microbiol. 1991 Oct;29(10):2107-10
pubmed: 1682341
Nat Methods. 2012 Jul 30;9(8):772
pubmed: 22847109
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Infect Genet Evol. 2008 Mar;8(2):191-204
pubmed: 18243816
Nat Biotechnol. 2011 May 15;29(7):644-52
pubmed: 21572440
J Infect Dis. 2011 May 15;203(10):1405-14
pubmed: 21502081
Nature. 2013 Apr 25;496(7446):504-7
pubmed: 23563266
Emerg Infect Dis. 2004 Apr;10(4):593-7
pubmed: 15200847
PLoS One. 2020 Jun 18;15(6):e0234508
pubmed: 32555732
PLoS One. 2016 Oct 5;11(10):e0163962
pubmed: 27706213
Am J Epidemiol. 1981 Nov;114(5):632-48
pubmed: 6272572
Trop Med Health. 2017 Nov 2;45:35
pubmed: 29118655
Cell. 2015 Jul 30;162(3):488-92
pubmed: 26232221
Infect Genet Evol. 2015 Jun;32:165-77
pubmed: 25784569
PLoS One. 2014 Nov 19;9(11):e112963
pubmed: 25409509
J Trop Med. 2018 Feb 15;2018:8127093
pubmed: 29666658
BMC Bioinformatics. 2009 Dec 15;10:421
pubmed: 20003500
Syst Biol. 2010 May;59(3):307-21
pubmed: 20525638

Auteurs

Aung Min Soe (AM)

Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.
Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8523, Japan.
Program for Nurturing Global Leaders in Tropical and Emerging Communicable Diseases, Nagasaki University, Nagasaki 852-8501, Japan.
Department of Medical Research, Yangon 11191, Myanmar.

Mya Myat Ngwe Tun (MM)

Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.

Takeshi Nabeshima (T)

Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.

Theingi Win Myat (TW)

Department of Medical Research, Yangon 11191, Myanmar.

Moh Moh Htun (MM)

Department of Medical Research, Yangon 11191, Myanmar.

Htin Lin (H)

Department of Medical Research, Yangon 11191, Myanmar.

Nang Sarm Hom (NS)

Department of Medical Research, Yangon 11191, Myanmar.

Shingo Inoue (S)

Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.
Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8523, Japan.

Khine Mya Nwe (KM)

Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.
Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8523, Japan.

Lynn Pa Pa Aye (LPP)

Department of Medical Research, Yangon 11191, Myanmar.

Mizuki Fukuta (M)

Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.
Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8523, Japan.

Kyaw Zin Thant (KZ)

Department of Medical Research, Yangon 11191, Myanmar.

Futoshi Hasebe (F)

Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8523, Japan.
Research Center for Infectious Disease Research in Asia and Africa, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.

Kouichi Morita (K)

Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.
Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8523, Japan.

Sujan Shresta (S)

La Jolla Institute for Immunology, La Jolla, CA 92037, USA.

Hlaing Myat Thu (HM)

Department of Medical Research, Yangon 11191, Myanmar.

Meng Ling Moi (ML)

Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.
Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8523, Japan.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH